Genetic Factors in Atherosclerosis and Artery Hardening

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on genetics and peptide-related health. Browse all Peptides & GLP-1 education

Atherosclerosis is the slow buildup of cholesterol-rich plaque inside artery walls, and it is the process behind most heart attacks and strokes. It develops quietly over decades, and how quickly it progresses is shaped by lifestyle, cholesterol biology, and inherited genetic factors that vary from person to person.

What Drives Artery Hardening

Artery hardening begins when LDL cholesterol particles cross the inner lining of a vessel and become oxidized. Immune cells respond, forming fatty streaks that gradually thicken into plaque. Over time the artery narrows and stiffens, and an unstable plaque can rupture and trigger a clot.

Blood pressure, smoking, blood sugar, chronic inflammation, and LDL cholesterol all accelerate this cycle. Genetics sits underneath these factors, influencing how efficiently your body clears cholesterol and how reactive your vessel walls are to injury.

Genes Linked to Atherosclerosis Risk

Cardiovascular genetics is one of the best-studied areas in medicine, and several named genes stand out. The LDLR gene encodes the LDL receptor that pulls cholesterol out of the bloodstream; loss-of-function variants raise LDL levels and are the classic cause of familial hypercholesterolemia. The PCSK9 gene regulates how many of those receptors survive on liver cells — gain-of-function variants reduce receptor recycling and push LDL higher, while loss-of-function variants are associated with lower lifetime cholesterol.

The APOB gene codes for the main protein on LDL particles, and certain variants change how tightly LDL binds its receptor. Separately, the chromosome 9p21 region (near CDKN2B-AS1) is one of the most consistently replicated coronary artery disease signals in large population studies, even though it does not act through cholesterol directly. Variation in LPA, which governs lipoprotein(a) levels, is another largely inherited contributor.

How Homocysteine and Methylation Fit In

The MTHFR gene affects folate metabolism and how the body clears homocysteine, an amino acid that at elevated levels has been associated with vascular stress in observational research. Common MTHFR variants such as C677T can reduce enzyme efficiency. This is a pathway-level tendency, not a verdict — nutrition, B-vitamin status, and provider guidance all shape the outcome.

Symptoms and When Arteries Are Already Narrowing

Early atherosclerosis usually causes no symptoms at all. As arteries narrow, warning signs depend on location: chest pressure or shortness of breath with exertion when coronary arteries are involved, leg pain while walking with peripheral disease, or sudden neurological symptoms when brain-supplying arteries are affected. Any of these warrants prompt medical evaluation.

How Clinicians Approach Prevention and Management

Managing atherosclerosis is a clinical decision made with a qualified provider. Evidence-based approaches generally focus on lowering LDL cholesterol, controlling blood pressure and blood sugar, stopping smoking, and building consistent physical activity. Clinicians tailor these decisions to each person's overall risk profile. Understanding your inherited tendencies can make that conversation more informed, but it does not replace it.

What Genetic Insight Adds

Genetics is a guide, not a guarantee. Knowing whether you carry variants that influence cholesterol handling or vascular biology gives context that generic risk calculators miss. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants across cardiovascular and metabolic pathways, to help you understand your baseline biology before you and your provider make a plan. PlexusDx tells you about your biology — it does not tell you what to put in your body.

Frequently Asked Questions

Is atherosclerosis inherited?

Atherosclerosis is influenced by inherited factors, not caused by a single gene. Variants in LDLR, PCSK9, APOB, and the 9p21 region shape baseline risk, while diet, blood pressure, smoking, and blood sugar determine how quickly plaque develops over your lifetime.

Can genetic testing diagnose heart disease?

No. Genetic testing does not diagnose heart disease or measure existing plaque. It provides pathway-level context about tendencies such as cholesterol clearance. Diagnosis requires clinical evaluation, imaging, and blood work interpreted by a qualified healthcare provider, not a DNA report alone.

Does the MTHFR variant mean I will get atherosclerosis?

No. An MTHFR variant reflects a tendency in folate metabolism and homocysteine clearance, not a diagnosis. Many carriers never develop vascular problems. Nutrition, B-vitamin status, and overall cardiovascular health matter more, and any concerns should be reviewed with your provider.

What can I do if I carry higher-risk variants?

Carrying higher-risk variants is information, not destiny. Use it to have a focused conversation with your provider about cholesterol testing, blood pressure, and lifestyle. Consistent physical activity, not smoking, and a heart-supportive diet remain the evidence-based levers everyone can act on.

Understanding your cardiovascular genetics starts with data. Explore the Precision Peptide Genetic Test to see how your genes influence the pathways behind artery health.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.